drugset / Trial / NCT03784300

A Safety Study of PTI-125 in Healthy Volunteers

NCT03784300 ↗

RandomizedParallel-groupTriple-blindPrevention

Summary

A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Pharmacokinetic and Safety Study of PTl-125 in Healthy Volunteers

Timeline

Start
2017-08-18
Primary completion
2017-10-09
Completion
2018-03-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Simufilam Small molecule 50 mg Oral
Comparator Simufilam Small molecule 100 mg Oral
Comparator Simufilam Small molecule 200 mg Oral